Puma Biotechnology
PBYI
PBYI
116 hedge funds and large institutions have $90M invested in Puma Biotechnology in 2025 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
+5
Holders Change %
+4.5%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
25
Increased
44
Reduced
25
Closed
19
Calls
$178K
Puts
$10K
Net Calls
+$168K
Net Calls Change
+$47K
Top Buyers
Top Sellers
| 1 |
EP
Eversept Partners
New York
|
$816K |
| 2 |
Millennium Management
New York
|
$4.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 4 |
JPMorgan Chase & Co
New York
|
$143K |
| 5 |
Squarepoint
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RWM
126
Ritholtz Wealth Management
New York
| – | -$61.4K | -20,128 | Closed |
|
|
BCM
127
Bayesian Capital Management
Brooklyn,
New York
| – | -$54K | -17,700 | Closed |
|
|
JG
128
Jain Global
New York
| – | -$36.2K | -11,871 | Closed |
|
129
ProShare Advisors
Bethesda,
Maryland
| – | -$36.2K | -11,853 | Closed |
|
|
PP
130
PDT Partners
New York
| – | -$34K | -11,131 | Closed |
|
131
Verition Fund Management
Greenwich,
Connecticut
| – | -$33.4K | -10,955 | Closed |
|
|
AACP
132
Advantage Alpha Capital Partners
San Francisco,
California
| – | -$20.7K | -6,796 | Closed |
|
|
RS
133
R Squared
Central,
Hong Kong
| – | -$15.3K | -5,020 | Closed |
|
|
CIAM
134
Caitong International Asset Management
Hong Kong
| – | -$406 | -133 | Closed |
|
|
RMP
135
Richards, Merrill & Peterson
Spokane,
Washington
| – | -$122 | -40 | Closed |
|